Skin Sensitization Test (Modified Draize-95 Test)

Inclusion Criteria: * Subjects must be aged 18 to 65 years, inclusive; * Subjects who have not participated in other voluntary testing for at least 30 days; * Subjects must execute an Informed Consent Form that includes a HIPAA statement; and * Subjects must be capable of understanding and following directions. * Female subjects must produce a negative urine pregnancy test prior to the initiation and also at the completion of the trial. Exclusion Criteria: * Subjects who are in ill health, as determined by the PI; * Subjects who are taking medication, other than birth control, which could influence the purpose, integrity or outcome of the trial; * Subjects who have used topical or systemic corticosteroids, anti-inflammatories, antihistamines or antibiotics within 2 weeks prior to trial initiation or during their participation on this trial; * Female subjects who are pregnant as evidenced by a urine pregnancy test, planning to become pregnant or lactating during the trial; * Subjects who have a history of adverse reactions to cosmetics, OTC drugs, or other personal care products; * Subjects who introduce the use of any new cosmetic, toiletry or personal care products during the trial; * Subjects with any visible skin disease that might be confused with skin reactions caused by the test material; * Subjects with any knowledge or indication of existing Type IV allergy (delayed hypersensitivity) to natural rubber chemical additives; * Subjects with any indication of existing Type I allergy (immediate hypersensitivity) to natural rubber proteins; * Subjects with a history of frequent irritation; or * Subjects who have received endogenous or exogenous immunosuppressive treatment (or prolonged exposure to sun).